Use of Raman spectrometry in the pharmaceutical field; ; et al in STP Pharma Pratiques (2013), 23(2), 97-117 This document sets out the theoretical and practical fundamentals to guide users in the imple- mentation of Raman spectroscopy in industry or the university-hospital sector. It describes the principle of ... [more ▼] This document sets out the theoretical and practical fundamentals to guide users in the imple- mentation of Raman spectroscopy in industry or the university-hospital sector. It describes the principle of this technique and currently available instruments. Since Raman spectrometers are used in a regulated context, the methodology of instru- ment qualification is discussed. Different types of applications encountered in the pharmaceutical field are presented: process monitoring, searching for and detecting counterfeits, and identifying raw materials on receipt. [less ▲] Detailed reference viewed: 16 (0 ULg) Quantitative analysis using near infrared spectroscopy, Application to tablet content uniformity, I. Methodology; ; et al in STP PHARMA PRATIQUES (2010), 20(2), 117-135 This first document describes guidelines to develop a quantification method for active pharmaceutical ingredient content in solid dose formulation, using near-infrared spectroscopy. This new approach ... [more ▼] This first document describes guidelines to develop a quantification method for active pharmaceutical ingredient content in solid dose formulation, using near-infrared spectroscopy. This new approach offers several advantages over classical techniques, in particular for tablets content uniformity determination. This document is intended to help users addressing the numerous questions pertaining to number and types of samples, usable spectral range for quantification, importance of the reference method, development of a model and potential pitfalls, use of chemometrics tools and method validation. It also offers a statistical support that used as an aid for decision for routine controls, when a sample falls near acceptance limits. The document gathers basic principles and will be complemented by a second article with practical examples to illustrate the methodology. [less ▲] Detailed reference viewed: 141 (34 ULg) Validation des procédures analytiques quantitatives, Harmonisation des démarchesHubert, Philippe ; ; Boulanger, Bruno et alin STP Pharma Pratiques (2003), 13(3), 101-138 Detailed reference viewed: 327 (43 ULg) Example of application of the new strategy proposed for the validation of chromatographic bioanalytical methods; ; et al in STP Pharma Pratiques (2000), 10(2), 79-101 Detailed reference viewed: 59 (8 ULg) New strategy for the validation of chromatographic bioanalytical methods; ; et al in STP Pharma Pratiques (2000), 10(1), 21-38 Detailed reference viewed: 70 (5 ULg) Techniques de préparation basées sur l'utilisation de membranes pour le traitement des échantillons biologiques préalable à leur analyse chromatographiqueChiap, Patrice ; Hubert, Philippe ; Crommen, Jacques ![]() in STP Pharma Pratiques (2000), 10(6), 361-374 Detailed reference viewed: 73 (8 ULg) Préparation des échantillons d'origine biologique préalable à leur analyse chromatographiqueHubert, Philippe ; Ceccato, Attilio ; Chiap, Patrice et alin STP Pharma Pratiques (1999), 9(2), 160-180 Detailed reference viewed: 62 (8 ULg) Méthodes chromatographiques de dosage dans les milieux biologiques : exemple d'application de la stratégie de validation - Rapport d'une commission SFSTP; ; et al in STP Pharma Pratiques (1998), 8(2), 81-107 Detailed reference viewed: 62 (5 ULg) Méthodes chromatographiques de dosage dans les milieux biologiques : stratégie de validation - Rapport d'une commission SFSTP; ; et al in STP Pharma Pratiques (1997), 7(3), 169-194 Detailed reference viewed: 91 (13 ULg) Formes pharmaceutiques à libération prolongée en médecine vétérinaire : systèmes à rétention dans le réticulo-rumen = Sustained-released veterinary dosage forms : retention devices in the reticulorumenEvrard, Brigitte ; Delattre, Luc ![]() in STP Pharma Pratiques (1996), 6(6), 479-486 L'industrialisation des productions animales a mis en évidence la nécessité d'éviter des administrations réitérées chez des animaux dont la manipulation est difficile, et de développer des formes à ... [more ▼] L'industrialisation des productions animales a mis en évidence la nécessité d'éviter des administrations réitérées chez des animaux dont la manipulation est difficile, et de développer des formes à libération contrôlée ou du moins fortement prolongée. L'anatomie particulière du tube digestive des ruminants offre en outre des possibilités inédites pour le développement de tels systèmes thérapeutiques, notamment grâce à la rétention dans le réticulo-rumen. De telles formes ont essentiellement été développées pour l'administration de médicaments antiparasitaires et antibactériens, de suppléments nutritionnels et de promoteurs croissance. Cette revue décrit les applications potentielles de la technologie des formes à libération contrôlée et prolongée en médecine vétérinaire et les différents dispositifs à rétention dans le réticulo-rumen décrits dans la littérature, brevetés ou commercialisés. More intensive methods ofanimal husbandry have revealed the necessity of avoiding repeated administration ofmedication to animals which are difficult to handle and of developing controlled and sustained release dosage forms. The physiological characteristics of the digestive tract of ruminants provide unique opportunity for controlled release technology, especially due to the animal's reticulo-rumen retention ability. The majorareas of application of these controlled and sustained release dosage forms include the delivery of antibiotic and antiparasitic agents, trace nutrients and growth promoting agents. This review describes the potential applications of controlled and sustained release technology in veterinary medicine and the various reticulo-rumen retention devices which are patented, marketed or described in the literature. [less ▲] Detailed reference viewed: 74 (2 ULg) |
||